Another advantage of these adenoviral vectors is that they can be double armed with any gene beside the one coding TRAIL to potentiate the tumoural cytotoxicity of the cancer targeted gene virotherapy (CTGVT) or to overcome TRAIL resistance. Here, TNFSF10 is linked to cancer.